Search Browse Earnings

Burning Rock Biotech Ltd — SlamSEC

Burning Rock Biotech Ltd

Nasdaq:BNR

Services-Medical Laboratories·GUANGZHOU, GUANGDONG

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$70.7M

-6.6% YoY

FY 2024

Adj. EBITDA

-$41.8M

-59.2% margin

FY 2024

Net Income

-$47.5M

-67.2% margin

FY 2024

EPS (Diluted)

—

Stock Price

$16.01

-29.9%

2026-03-13

52W Range

$2.18 – $41.72

P/E Ratio

—

Market Cap

—

Cash

$71.2M

FY 2024

Total Debt

—

Net Cash

$71.2M

FY 2020

Enterprise Value

—

Debt / EBITDA

1.7x

FY 2024

EV / EBITDA

—

Employees

—